foxo4-dri peptide senolytic 2023 Frontiers FOXO4-DRI - Averix Labs
FOXO4 DRI Averix Labs FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



